Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H23NO5 |
Molecular Weight | 333.3789 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12[C@H]3CCN1CC=C2COC(=O)[C@](C)(O)C(=C)C\C(=C\C)C(=O)O3
InChI
InChIKey=FCEVNJIUIMLVML-QPSVUOIXSA-N
InChI=1S/C18H23NO5/c1-4-12-9-11(2)18(3,22)17(21)23-10-13-5-7-19-8-6-14(15(13)19)24-16(12)20/h4-5,14-15,22H,2,6-10H2,1,3H3/b12-4-/t14-,15-,18-/m1/s1
Seneciphylline, a pyrrolizidine alkaloid, the one of the main component of Chinese medicine herb Tusanqi, which is a reason of the hepatic sinusoidal obstruction syndrome (HSOS). In addition, experiments on rats have shown that seneciphylline had adverse effects on the development and organic morphodifferentiation of embryos, thus the pregnant people exposed to Hebra may get potential risk on the fetus.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Seneciphylline. | 1976 |
|
Covalent binding of two pyrrolizidine alkaloids, senecionine and seneciphylline, to hepatic macromolecules and their distribution, excretion, and transfer into milk of lactating mice. | 1982 May-Jun |
|
Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991 Jan-Feb |
|
An in vitro comparison of the cytotoxic potential of selected dehydropyrrolizidine alkaloids and some N-oxides. | 2015 Apr |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22188914
Curator's Comment: Hepatic sinusoidal obstruction syndrome (HSOS) induced by a Chinese medicinal herb Tusanqi
seneciphylline is a part of Chinese medicinal herb Tusanqi
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25518325
It was evaluated the embryotoxicity of alkaloids in Senecionis Scandentis Hebra on in vitro cultured mouse embryos. Post-implantation (8.5 d) mouse embryos were isolated from their mothers, and cultured in the medium of immediately centrifuged serum (ICS) with different concentrations of seneciphylline (target concentrations were 100, 50, 25 and 12.5 μg x mL(-1)) for 48 h. Treatment with seneciphylline had adverse effects on the development and organic morphodifferentiation of embryos.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5281750
Created by
admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
|
PRIMARY | |||
|
5188
Created by
admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
|
PRIMARY | |||
|
DTXSID8026016
Created by
admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
|
PRIMARY | |||
|
m9861
Created by
admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
|
PRIMARY | Merck Index | ||
|
C013678
Created by
admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
|
PRIMARY | |||
|
480-81-9
Created by
admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
|
PRIMARY | |||
|
0ZYZ9L5454
Created by
admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
|
PRIMARY | |||
|
30622
Created by
admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD